The groundbreaking therapy of this peptide represents a significant development in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets multiple pathways – GLP-1 and GIP – https://tirzepatidepeptide676224.jaiblogs.com/69172932/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment